Roy Fleischmann
0000-0002-6630-1477
University of Texas Southwestern Medical Center at Dallas
6 papers found
Refreshing results…
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update
Current Treatment Strategies in Rheumatoid Arthritis After Methotrexate Are Not Enough to Maintain Sustained Remission: There Is No Holy Grail!
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research
4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis
Editorial: The American College of Rheumatology White Paper on Biosimilars: It Isn't All White-There Is Some Gray and Black
Missing publications? Search for publications with a matching author name.